Nuzenio

Lacutamab Ahead

Lacutamab Ahead news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Sobi Inks $580 Million Deal With Innate Pharma for Skin Cancer Drug Lacutamab Ahead of Pivotal Trial - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 18:41:00 GMTSobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 push - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:13:48 GMTFinancialContent - Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer - FinancialContentFinancialContent · Mon, 10 Aug 2026 06:30:00 GMTInnate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma - Business WireBusiness Wire · Mon, 10 Aug 2026 06:00:00 GMT

Timeline

Mon, 10 Aug 2026 18:41:00 GMTSobi Inks $580 Million Deal With Innate Pharma for Skin Cancer Drug Lacutamab Ahead of Pivotal Trial - finance.biggo.com
Mon, 10 Aug 2026 11:13:48 GMTSobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 push - Fierce Biotech
Mon, 10 Aug 2026 06:30:00 GMTFinancialContent - Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer - FinancialContent
Mon, 10 Aug 2026 06:00:00 GMTInnate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lacutamab Ahead.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.